La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Titre (en) » - entrée « effect »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
eep < effect < effective  Facettes :

List of bibliographic references indexed by effect

Number of relevant bibliographic references: 225.
[0-50] [0 - 20][0 - 50][50-70]
Ident.Authors (with country if any)Title
000055 (2017) Renato P. Munhoz [Canada] ; Delcio Bertucci Filho [Brésil] ; Hélio A G. Teive [Brésil]Not all drug-induced parkinsonism are the same: the effect of drug class on motor phenotype.
000096 (2017) Olivier Girard-Joyal [Canada] ; Nafissa Ismail [Canada]Effect of LPS treatment on tyrosine hydroxylase expression and Parkinson-like behaviors.
000179 (2016) Fiona E. Parkinson [Canada] ; Soumen Paul [Canada] ; Dali Zhang [Canada] ; Shadreck Mzengeza [Canada] ; Ji Hyun Ko [Canada]The Effect of Endogenous Adenosine on Neuronal Activity in Rats: An FDG PET Study.
000180 (2016) Daniel J. Cameron [Canada] ; Kristen A. Pickett [États-Unis] ; Gammon M. Earhart [États-Unis] ; Jessica A. Grahn [Canada]The Effect of Dopaminergic Medication on Beat-Based Auditory Timing in Parkinson’s Disease
000198 (2016) Alfonso Fasano [Canada] ; Christian Schlenstedt [Allemagne] ; Jan Herzog [Allemagne] ; Meir Plotnik [Israël] ; Franziska E M. Rose [Allemagne] ; Jens Volkmann [Allemagne] ; Günther Deuschl [Allemagne]Split-belt locomotion in Parkinson's disease links asymmetry, dyscoordination and sequence effect.
000265 (2016) Priti Gros [Canada] ; Victoria P. Mery [Chili] ; Anne-Louise Lafontaine [Canada] ; Ann Robinson [Canada] ; Andrea Benedetti [Canada] ; R John Kimoff [Canada] ; Marta Kaminska [Canada]Obstructive sleep apnea in Parkinson's disease patients: effect of Sinemet CR taken at bedtime.
000294 (2016) Michél Rathbone [Canada] ; William Parkinson [Canada] ; Yasir Rehman [Canada] ; Shucui Jiang [Canada] ; Mohit Bhandari [Canada] ; Dinesh Kumbhare [Canada]Magnitude and variability of effect sizes for the associations between chronic pain and cognitive test performances: a meta-analysis.
000374 (2016) Cassandra M. Mccaig [Canada] ; Scott G. Adams [Canada] ; Allyson D. Dykstra [Canada] ; Mandar Jog [Canada]Effect of concurrent walking and interlocutor distance on conversational speech intensity and rate in Parkinson's disease.
000388 (2016) Alvin Yang [Canada] ; Tahira Daya [Canada] ; Karen Carlton [Canada] ; Jin Hui Yan [Canada] ; Susanne Schmid [Canada]Differential effect of clomipramine on habituation and prepulse inhibition in dominant versus subordinate rats.
000504 (2015) Vibhor Krishna [Canada] ; Gavin Elias [Canada] ; Francesco Sammartino [Canada] ; Diellor Basha [Canada] ; Nicolas K K. King [Canada] ; Alfonso Fasano [Canada] ; Renato Munhoz [Canada] ; Suneil K. Kalia [Canada] ; Mojgan Hodaie [Canada] ; Lashmi Venkatraghavan [Canada] ; Andres M. Lozano [Canada] ; William D. Hutchison [Canada]The effect of dexmedetomidine on the firing properties of STN neurons in Parkinson's disease.
000514 (2015) Ma N Obeidat [Canada] ; Nick Fishbane [Canada] ; Yunlong Nie [Canada] ; Virginia Chen [Canada] ; Zsuzsanna Hollander [Canada] ; Scott J. Tebbutt [Canada] ; Yohan Bossé [Canada] ; Raymond T. Ng [Canada] ; Bruce E. Miller [États-Unis] ; Bruce Mcmanus [Canada] ; Stephen Rennard [États-Unis] ; Peter D. Paré [Canada] ; Don D. Sin [Canada]The Effect of Statins on Blood Gene Expression in COPD
000553 (2015) Sarah Pirio Richardson [États-Unis] ; Sule Tinaz [États-Unis] ; Robert Chen [Canada]Repetitive Transcranial Magnetic Stimulation in Cervical Dystonia: Effect of Site and Repetition in a Randomized Pilot Trial
000571 (2015) Madison T. Gray [Canada] ; David G. Munoz [Canada] ; Michael G. Schlossmacher [Canada] ; Douglas A. Gray [Canada] ; John M. Woulfe [Canada]Protective effect of vagotomy suggests source organ for Parkinson disease.
000581 (2015) Alberto J. Espay ; Matthew M. Norris ; James C. Eliassen ; Alok Dwivedi ; Matthew S. Smith ; Christi Banks ; Jane B. Allendorfer ; Anthony E. Lang ; David E. Fleck ; Michael J. Linke ; Jerzy P. SzaflarskiPlacebo effect of medication cost in Parkinson disease
000582 (2015) Kaviraja Udupa [Canada] ; Susan H. Fox [Canada]Placebo effect in Parkinson's disease: Harnessing the mind in the treatment of PD.
000625 (2015) Weitao Zhou ; Xiaoyong Li ; Daochao Huang ; Weihui Zhou ; Tingyu Li ; Weihong Song [République populaire de Chine]No significant effect of 7,8-dihydroxyflavone on APP processing and Alzheimer-associated phenotypes.
000666 (2015) Ziv Gan-Or [Canada] ; Claire S. Leblond [Canada] ; Victoria Mallett [Canada] ; Avi Orr-Urtreger [Israël] ; Patrick A. Dion [Canada] ; Guy A. Rouleau [Canada]LRRK2 mutations in Parkinson disease; a sex effect or lack thereof? A meta-analysis.
000747 (2015) Karl Kieburtz [États-Unis] ; Barbara C. Tilley ; Jordan J. Elm ; Debra Babcock [États-Unis] ; Robert Hauser [États-Unis] ; G Webster Ross [États-Unis] ; Alicia H. Augustine [États-Unis] ; Erika U. Augustine [États-Unis] ; Michael J. Aminoff [États-Unis] ; Ivan G. Bodis-Wollner ; James Boyd ; Franca Cambi ; Kelvin Chou ; Chadwick W. Christine [États-Unis] ; Michelle Cines [États-Unis] ; Nabila Dahodwala [États-Unis] ; Lorelei Derwent [Canada] ; Richard B. Dewey ; Katherine Hawthorne [États-Unis] ; David J. Houghton [États-Unis] ; Cornelia Kamp [États-Unis] ; Maureen Leehey ; Mark F. Lew [États-Unis] ; Grace S Lin Liang [États-Unis] ; Sheng T. Luo ; Zoltan Mari [États-Unis] ; John C. Morgan ; Sotirios Parashos [États-Unis] ; Adriana Pérez ; Helen Petrovitch [États-Unis] ; Suja Rajan ; Sue Reichwein [États-Unis] ; Jessie Tatsuno Roth [États-Unis] ; Jay S. Schneider [États-Unis] ; Kathleen M. Shannon [États-Unis] ; David K. Simon [États-Unis] ; Tanya Simuni [États-Unis] ; Carlos Singer [États-Unis] ; Lewis Sudarsky [États-Unis] ; Caroline M. Tanner [États-Unis] ; Chizoba C. Umeh [États-Unis] ; Karen Williams [États-Unis] ; Anne-Marie Wills [États-Unis]Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial.
000748 (2015) Mariano Serrao [Italie] ; Alberto Ranavolo [Italie] ; Carmela Conte [Italie] ; Chiara Davassi [Italie] ; Silvia Mari [Italie] ; Alfonso Fasano [Canada] ; Giorgia Chini [Italie] ; Gianluca Coppola [Italie] ; Francesco Draicchio [Italie] ; Francesco Pierelli [Italie]Effect of 24-h continuous rotigotine treatment on stationary and non-stationary locomotion in de novo patients with Parkinson disease in an open-label uncontrolled study.
000905 (2014) Julie Nantel [Canada] ; Helen Bronte-Stewart [États-Unis]The effect of medication and the role of postural instability in different components of freezing of gait (FOG).
000A54 (2014) Sarah Christine Lidstone [Canada]Great expectations: the placebo effect in Parkinson's disease.
000A76 (2014) Atsuko Nagano-Saito [Canada] ; Claudine Habak ; Beatriz Mejía-Constaín ; Clotilde Degroot ; Laura Monetta ; Thomas Jubault ; Christophe Bedetti ; Anne-Louise Lafontaine ; Sylvain Chouinard ; Valérie Soland ; Alain Ptito ; Antonio P. Strafella ; Oury MonchiEffect of mild cognitive impairment on the patterns of neural activity in early Parkinson's disease.
000A77 (2014) Stephanie Chu [Canada] ; Wei Xiong ; Fiona E. ParkinsonEffect of ecto-5'-nucleotidase (eN) in astrocytes on adenosine and inosine formation.
000A78 (2014) Lisa-Ann Fraser [Canada] ; Jonathan D. Adachi [Canada] ; William D. Leslie [Canada] ; David Goltzman [Canada] ; Robert Josse [Canada] ; Jerilynn Prior [Canada] ; Stephanie Kaiser [Canada] ; Nancy Kreiger [Canada] ; Christopher S. Kovacs [Canada] ; Tassos P. Anastassiades [Canada] ; Alexandra Papaioannou [Canada]Effect of Anticholinergic Medications on Falls, Fracture Risk, and Bone Mineral Density Over a 10-Year Period
000A91 (2014) Katerina Markopoulou [États-Unis] ; Joanna M. Biernacka [États-Unis] ; Sebastian M. Armasu [États-Unis] ; Kari J. Anderson [États-Unis] ; J. Eric Ahlskog [États-Unis] ; Bruce A. Chase [États-Unis] ; Sun Ju Chung [Corée du Sud] ; Julie M. Cunningham [États-Unis] ; Matthew Farrer [Canada] ; Roberta Frigerio [États-Unis] ; Demetrius M. Maraganore [États-Unis]Does α-Synuclein Have A Dual and Opposing Effect in Preclinical versus Clinical Parkinson’s Disease?
000B38 (2014) Kristina Martinu [Canada] ; Atsuko Nagano-Saito [Canada] ; Stuart Fogel [Canada] ; Oury Monchi [Canada]Asymmetrical Effect of Levodopa on the Neural Activity of Motor Regions in PD
000B55 (2014) Véronique Daneault [Canada] ; Marc Hébert ; Geneviève Albouy [Canada] ; Julien Doyon [Canada] ; Marie Dumont [Canada] ; Julie Carrier [Canada] ; Gilles Vandewalle [Canada]Aging Reduces the Stimulating Effect of Blue Light on Cognitive Brain Functions
000B83 (2014) Stéphanie Bissonnette [Canada] ; Sophie Muratot [Canada] ; Nathalie Vernoux [Canada] ; François Bezeau [Canada] ; Frédéric Calon [Canada] ; Sébastien S. Hebert [Canada] ; Pershia Samadi [Canada]The effect of striatal pre-enkephalin overexpression in the basal ganglia of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease
000C12 (2014) Tiago A. Mestre [Canada] ; Prakesh Shah [Canada] ; Connie Marras [Canada] ; George Tomlinson [Canada] ; Anthony E. Lang [Canada]Another face of placebo: The lessebo effect in Parkinson disease: Meta-analyses
000C14 (2014) Arthur G. Fitzmaurice [États-Unis] ; Shannon L. Rhodes [États-Unis] ; Myles Cockburn [États-Unis] ; Beate Ritz [États-Unis] ; Jeff M. Bronstein [États-Unis, Canada]Aldehyde dehydrogenase variation enhances effect of pesticides associated with Parkinson disease
000C41 (2013) Michael G. Heckman [États-Unis] ; Alexis Elbaz [France] ; Alexandra I. Soto-Ortolaza [États-Unis] ; Daniel J. Serie [États-Unis] ; Jan O. Aasly [Norvège] ; Grazia Annesi [Italie] ; Georg Auburger [Allemagne] ; Justin A. Bacon [États-Unis] ; Magdalena Boczarska-Jedynak [Pologne] ; Maria Bozi [Grèce] ; Laura Brighina [Italie] ; Marie-Christine Chartier-Harlin [France] ; Efthimios Dardiotis [Grèce] ; Alain Destée [France] ; Carlo Ferrarese [Italie] ; Alessandro Ferraris [Italie] ; Brian Fiske [États-Unis] ; Suzana Gispert [Allemagne] ; Georgios M. Hadjigeorgiou [Grèce] ; Nobutaka Hattori [Japon] ; John P. A. Ioannidis [Grèce, États-Unis] ; Barbara Jasinska-Myga [Pologne] ; Beom S. Jeon [Corée du Sud] ; Yun Joong Kim [Corée du Sud] ; Christine Klein [Allemagne] ; Rejko Kruger [Allemagne] ; Elli Kyratzi [Grèce] ; Chin-Hsien Lin [Taïwan] ; Katja Lohmann [Allemagne] ; Marie-Anne Loriot [France] ; Timothy Lynch [Irlande (pays)] ; George D. Mellick [Australie] ; Eugénie Mutez [France] ; Grzegorz Opala [Pologne] ; Sung Sup Park [Corée du Sud] ; Simona Petrucci [Italie] ; Aldo Quattrone [Italie] ; Manu Sharma [Allemagne] ; Peter A. Silburn [Australie] ; Young Ho Sohn [Corée du Sud] ; Leonidas Stefanis [Grèce] ; Vera Tadic [Allemagne] ; Hiroyuki Tomiyama [Japon] ; Ryan J. Uitti [États-Unis] ; Enza Maria Valente [Italie] ; Demetrios K. Vassilatis [Grèce] ; Carles Vilari O-Güell [Canada] ; Linda R. White [Norvège] ; Karin Wirdefeldt [Suède] ; Zbigniew K. Wszolek [États-Unis] ; Ruey-Meei Wu [Taïwan] ; Georgia Xiromerisiou [Grèce] ; Demetrius M. Maraganore [États-Unis] ; Matthew J. Farrer [Canada] ; Owen A. Ross [États-Unis]The protective effect of LRRK2 p.R1398H on risk of Parkinson’s disease is independent of MAPT and SNCA variants
000C81 (2013) Justine Renaud ; Julie Bournival ; Ximena Zottig ; Maria-Grazia MartinoliResveratrol Protects DAergic PC12 Cells from High Glucose-Induced Oxidative Stress and Apoptosis: Effect on p53 and GRP75 Localization
000D37 (2013) Danielle Murray [Canada] ; A Jon StoesslMechanisms and therapeutic implications of the placebo effect in neurological and psychiatric conditions.
000D41 (2013) Jing Shen [République populaire de Chine] ; Mohammad A. Kassir [États-Unis] ; Jianlin Wu [République populaire de Chine] ; Qing Zhang [République populaire de Chine] ; Shiyu Zhou [République populaire de Chine] ; Stephanie Y. Xuan [Canada] ; Qinghang Li [États-Unis] ; Yongquan Ye [États-Unis] ; Jiani Hu [États-Unis]MR Volumetric Study of Piriform-Cortical Amygdala and Orbitofrontal Cortices: The Aging Effect
000D52 (2013) Joan Parkinson [Canada] ; Heather Sandusky ; Francois TremblayInterocular effect during visual acuity measurement with and without amblyopia.
000E49 (2013) Ronald B. Postuma [Canada] ; Jean-Francois Gagnon [Canada] ; Maria Tuineaig [Canada] ; Josie-Anne Bertrand [Canada] ; Veronique Latreille [Canada] ; Catherine Desjardins [Canada] ; Jacques Y. Montplaisir [Canada]Antidepressants and REM Sleep Behavior Disorder: Isolated Side Effect or Neurodegenerative Signal?
000F63 (2013) Alex A. Macdonald [Canada] ; Oury Monchi [Canada] ; Ken N. Seergobin [Canada] ; Hooman Ganjavi [Canada] ; Ruzbeh Tamjeedi [Canada] ; Penny A. Macdonald [Canada]Parkinson's disease duration determines effect of dopaminergic therapy on ventral striatum function
000F87 (2013) Tobias Krettenauer [Canada] ; Fanli Jia [Canada]Investigating the actor effect in moral emotion expectancies across cultures: A comparison of Chinese and Canadian adolescents
001059 (2013) Danielle Murray [Canada] ; A. Jon Stoessl [Canada]Mechanisms and therapeutic implications of the placebo effect in neurological and psychiatric conditions
001109 (2012) Rahman Md Mostafeezur [Japon] ; Hossain Md Zakir [Japon] ; Yoshiaki Yamada [Japon] ; Kensuke Yamamura [Japon] ; Koichi Iwata [Japon] ; Barry J. Sessle [Canada] ; Junichi Kitagawa [Japon]The effect of minocycline on the masticatory movements following the inferior alveolar nerve transection in freely moving rats
001110 (2012) Shady Rahayel [Canada] ; Johannes Frasnelli ; Sven JoubertThe effect of Alzheimer's disease and Parkinson's disease on olfaction: a meta-analysis.
001161 (2012) Tiffiny Chan ; Ari M. Chow ; Xin R. Cheng ; Derek X0a W. F. Tang ; Ian R. Brown ; Kagan KermanOxidative Stress Effect of Dopamine on α-Synuclein: Electroanalysis of Solvent Interactions
001199 (2012) Hanifi Soylu [Canada] ; Dali Zhang ; Richard Buist ; Melanie Martin ; Benedict C. Albensi ; Fiona E. ParkinsonIntracortical injection of endothelin-1 induces cortical infarcts in mice: effect of neuronal expression of an adenosine transporter.
001246 (2012) Sang Soo Cho [Canada] ; Giovanna Pellecchia [Canada] ; Ji Hyun Ko [Canada] ; Nicola Ray [Canada] ; Ignacio Obeso [Canada] ; Sylvain Houle [Canada] ; Antonio P. Strafella [Canada]Effect of continuous theta burst stimulation of the right dorsolateral prefrontal cortex on cerebral blood flow changes during decision making
001441 (2012) S. Al-Sweidi [Canada] ; M. Morissette [Canada] ; T. Di Paolo [Canada]Effect of Oestrogen Receptors on Brain NMDA Receptors of 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine Mice
001456 (2012) Mina Mhallem Gziri [Belgique] ; Frédéric Debiève [Belgique] ; Luc De Catte [Belgique] ; Luc Mertens [Belgique, Canada] ; Catherine Barrea [Belgique] ; Kristel Van Calsteren [Belgique] ; Sileny N. Han [Belgique] ; Liesbeth Heyns [Belgique] ; Frédéric Amant [Belgique]Chemotherapy during pregnancy: effect of anthracyclines on fetal and maternal cardiac function
001479 (2012) Jo Watson [Canada] ; Ellen Hodnett ; B. Anthony Armson ; Barbara Davies ; Judy Watt-WatsonA Randomized Controlled Trial of the Effect of Intrapartum Intravenous Fluid Management on Breastfed Newborn Weight Loss
001480 (2012) H. Soylu ; D. Zhang ; R. Buist [Canada] ; M. Martin [Canada] ; Bc Albensi ; Fe Parkinson1842 Effect of Neuronal Expression of Hent1 and Caffeine on Cerebral Blood Flow and Cortical Stroke in Mice
001533 (2012) Elaine M. Dennison [Royaume-Uni, Nouvelle-Zélande] ; Juliet E. Compston [Royaume-Uni] ; Julie Flahive [États-Unis] ; Ethel S. Siris [États-Unis] ; Stephen H. Gehlbach [États-Unis] ; Jonathan D. Adachi [Canada] ; Steven Boonen [Belgique] ; Roland Chapurlat [France] ; Adolfo Diez-Perez [Espagne] ; Frederick A. Jr Anderson [États-Unis] ; Frederick H. Hooven [États-Unis] ; Andrea Z. Lacroix [États-Unis] ; Robert Lindsay [États-Unis] ; J. Coen Netelenbos [Pays-Bas] ; Johannes Pfeilschifter [Allemagne] ; Maurizio Rossini [Italie] ; Christian Roux [France] ; Kenneth G. Saag [États-Unis] ; Philip Sambrook [Australie] ; Stuart Silverman [États-Unis] ; Nelson B. Watts [États-Unis] ; Susan L. Greenspan [États-Unis] ; Melissa Premaor ; Cyrus Cooper [Royaume-Uni]Effect of co-morbidities on fracture risk: Findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW)
001534 (2012) Golnasim Riahi [Canada] ; Marc Morissette [Canada] ; Daniel Levesque [Canada] ; Claude Rouillard [Canada] ; Pershia Samadi [Canada] ; Martin Parent [Canada] ; Thérèse Di Paolo [Canada]Effect of chronic L-DOPA treatment on 5-HT1A receptors in parkinsonian monkey brain
001535 (2012) I. H. Mustafa [Canada] ; A. Elkamel [Canada] ; P. Chen [Canada] ; G. Ibrahim [Égypte] ; S. S. E. H. Elnashaie [États-Unis]Effect of cholineacetyltransferase activity and choline recycle ratio on diffusion-reaction modeling, bifurcation and chaotic behavior of acetylcholine neurocycle and their relation to Alzheimer's and Parkinson's diseases

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "effect" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "effect" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    effect
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022